ArticleFrontiers in aging2026
Electronic health records reveals resilience patterns of cardiovascular disease in Basque centenarians.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Although their prevalence increases with age, their impact on centenarians remains poorly understood. Methods: We analyzed Electronic Health Records (EHRs) to assess the incidence and effect of CVDs in centenarians (n = 649) and non-centenarians (n = 62,753) in the Basque Country. Descriptive statistics were applied to discern differences between the two population groups in terms of prevalence, number of diagnoses, and treatments. Survival analysis was performed through Kaplan-Meier estimator. Trajectories of laboratory parameters were explored through non-linear mixed models (NLMMs). Results: Centenarians had lower incidence of severe conditions such as ischemic heart disease, despite overall CVD incidence being similar between groups. Survival analyses revealed extended longevity in centenarians after both first and last CVD diagnosis. Biomarker trajectories suggested favorable biological profiles with greater resilience and faster recovery in centenarians. Conclusion: Despite experiencing CVDs, centenarians demonstrate delayed onset, reduced severity, and more favorable biological recovery compared to non-centenarians. These findings indicate potential resilience mechanisms that may contribute to healthy ageing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.